Framework Agreement for the Provision of Viscoelastics
key details
| Status | planned |
|---|---|
| Category (CPV) | 33600000 |
| Contract start | 1 Jan 2024 |
| Contract end | 31 Dec 2026 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-b5fd17-3a67322d-6eed-4b7e-aa84-4817c9f93663 |
description
The purpose of this tender is to put in place a Framework Agreement for the supply of Viscoelastic products for use in participating Trusts
The contract will be for Sodium hyaluronate syringes for use in ophthalmic surgery. All products must conform to EU and UK Legislation.
The East Midlands Pharmacy Collaborative (EMPC) hosted by The University Hospitals of Derby & Burton NHS Foundation Trusts has collated the requirements of the following Trusts who may or may not be participating in this offer, subject to the terms of any existing agreements. Hereafter all references to Pharmacy Collaborative will incorporate these Trusts also. Inclusion of ICB's / Mental health Trusts across the region may be required at a later stage.
Current Acute Membership is listed below but is subject to change throughout the life of any resulting contract. The following web address provides the most up to date member list. https://www.empc.nhs.uk/
The Purchasing Collaborative Organisations that are listed under The Specialist Pharmacy Service may participate in this Framework during the Contract period. Please see the current list at: https://www.sps.nhs.uk/articles/collaborative-purchasing-organisations/
Framework agreement may extend to: All National Health Service (NHS) bodies in England, including but not limited to:
NHS Provider Directory
https://www.england.nhs.uk/publication/nhs-provider-directory/
NHS Foundation Trusts at:
https://www.england.nhs.uk/wp-content/uploads/2019/04/Public_Registry_FT_directory_190403.xls
This is a two-year contract with the option to extend for a further 2 years at the discretion of the EMPC and provider(s) agreement.
Additional information: This is a two-year contract with the option to extend for a further 2 years at the discretion of the EMPC and provider(s) agreement.
The current annual value with the EMPC members is £65,000 per annum
The estimated contract value is in the region of £800,000 (for the 4 year Framework period), depending on Contract take up by the Trusts listed in 4 (Description) above.
The procurement documents are available for unrestricted and full direct access, free of charge, at https://emprocurenhs.bravosolution.co.uk/web/login.shtml
For full access to the documents and to be able to submit a bid please go to the web address above and register. Once registered you can find the invitation to tender by searching the ref D98
For any technical problems with the procurement portal please contact the Bravo eTendering helpdesk:
Phone: 0800 069 8630
E-mail: help@bravosolution.co.uk
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 20 Mar 2023 | Planning (planning) | · | 7232abca-402c-43da-9342-1299a49e4764-621228 |
more from UNIVERSITY HOSPITALS OF DERBY & BURTON NHS FOUNDATION TRUST
- Provision of OPTOMIZE Diabetic Eye Screening Software · £350,000 · 23 Mar 2026
- Supply of Enteral Feeds Consumables inc Home Delivery · £100,000 · 4 Apr 2025
- Supply of Glaucoma Treatment System · £32,000 · 7 Jun 2024
- Supply of Magnetic Seeds for Non-Wire Lesion Localisation · £50,000 · 26 Apr 2024
- Management and Refresh of Emergency Response Boxes · £54,000 · 19 Mar 2024
- Framework Agreement for the Provision of Balanced Salt Solution Products · £1 · 27 Sept 2023
- Framework for the Supply of Viscoelastics · 22 Sept 2023
- Framework Agreement for the Supply of X-Ray Contrast Media and Barium Products · £20,000,000 · 25 Aug 2023
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.